Moffitt at ASCO 2024

Could a Quick Electronic Assessment Improve Outcomes for Older People with Pancreatic Cancer?

Study shows correlation between electronic frailty index and chemotherapy toxicity among octogenarians

‘Daily Diary’ Study Monitors Caregiver Stress and Mood

It’s part of a larger study to support caregivers and improve patient outcomes

Moffitt Scientists Present Groundbreaking Clinical Research at ASCO

Presentations include advances in targeted therapies, immunotherapy and patient care

Percutaneous Hepatic Perfusion Should Be Done First and Early for Metastatic Uveal Melanoma Patients

The pivotal phase III FOCUS study shows percutaneous hepatic perfusion (PHP) is best option

New Study Reveals HPV Vaccine Benefits Men, Too

Findings underscore vaccine's effectiveness in preventing not only cervical cancer but also head and neck cancers in males

Targeted Therapy Shows Promise as Earlier Treatment for Metastatic Breast Cancer

Enhertu proves effective in HER2-low metastatic breast cancer with disease progression after endocrine therapy

Landmark Lung Cancer Studies Set to Alter Standard of Care

New data reveals significant survival benefits for patients with stage 3 unresectable non-small cell and limited-stage small cell lung cancers

New Drug Shows Promise for Chronic Myeloid Leukemia Patients

Asciminib outperforms standard therapies in phase 3 trial

Next Generation of TIL Therapy Being Developed for Head and Neck Cancers

Standard of care fails 80% of patients with advanced squamous cell carcinoma